Recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225 Conditions Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more Locations MPN Research Foundation — Chicago, Illinois, United States Memorial Sloan Kettering Cancer Center — New York, United States View Trial Details
Completed Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MF NCT01392443 Conditions Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more Locations Novartis Investigative Site — Beijing, Beijing Municipality, China Novartis Investigative Site — Guangzhou, Guangdong, China Novartis Investigative Site — Wuhan, Hubei, China Novartis Investigative Site — Nanjing, Jiangsu, China View all 26 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis NCT02087059 Conditions Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more Locations Novartis Investigative Site — Nagoya, Aichi-ken, Japan Novartis Investigative Site — Akita, Japan Novartis Investigative Site — Matsuyama, Ehime, Japan Novartis Investigative Site — Tōon, Ehime, Japan View all 29 locations View more locations Show fewer locations Loading locations... View Trial Details
